- LncRNA ANRIL promotes multiple myeloma progression and bortezomib res…
Number of the records: 1  

LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN

  1. YANG, Li-Hui. LncRNA ANRIL promotes multiple myeloma progression and bortezomib resistance by EZH2-mediated epigenetically silencing of PTEN. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2021, 2021, vol. 68, no. 4, s. 788-797.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.